Health Care & Life Sciences » Pharmaceuticals | Boryung Pharmaceutical Co. Ltd.

Boryung Pharmaceutical Co. Ltd.

Boryung Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW582.15
Market Cap
KRW493.97 B
Shares Outstanding
44.2 M
Public Float
18.53 M

Profile

Address
Boryung Building
Seoul SL 03127
Korea, Republic Of
Employees -
Website http://www.boryung.co.kr
Updated 07/08/2019
Boryung Pharmaceutical Co., Ltd. engages in the manufacture of of drug products. Its main products include Kanarb, Dukarb, Tuvero, TODULA, BESTO, and gelfosM. Its products include cardiovascular, antibiotics, anticancer, amino acid, cosmetics, gastrointestinal, and API.

Financials

View All

Eun-Sun Kim
Co-Chief Executive Officer & Director
Tae-Hong Choi
Co-Chief Executive Officer & Director